Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

21.63
Delayed Data
As of 3:59pm ET
 +0.48 / +2.27%
Today’s Change
10.85
Today|||52-Week Range
33.82
+14.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Operating ActivitiesNet Income / Starting Line-6.2B689.4M-11.7B1.2B
 
 
 
 
 
Depreciation598.2M525.5M508.1M516.5M
 
 
 
 
 
Total Other Cash Flow6.5B591.6M13.6B696.9M
 
 
 
 
 
Funds From Operations993.5M1.2B742.7M2.1B
 
 
 
 
 
Funds From/For Other Operating Expenses225.7M62.1M-409.9M619.4M
 
 
 
 
 
Net Cash Flow - Operating Activities767.8M1.1B1.2B1.5B
 
 
 
 
 
 
InvestingCapital Expenditures-200.2M-211.8M-259.8M-166.1M
 
 
 
 
 
Fixed Asset Disposal79.4M150.2M1.9B839.5M
 
 
 
 
 
Other Investing - Uses-281.4M-171.0M-4.1M-67.2M
 
 
 
 
 
Other Investing - Sources0.00----452.3M
 
 
Net Cash Flow Investing-402.2M-232.6M1.6B1.1B
 
 
 
 
 
 
FinancingShort Term Borrowings-135.1M-138.1M-29.1M-265.9M
 
 
 
 
 
Long Term Borrowings538.9M-20.8M-8.6M4.5B
 
 
 
 
 
Long Term Debt Reduction-603.0M-424.1M-2.3B-6.4B
 
 
 
 
 
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total-425.2M-182.0M-138.0M-22.4M
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing53.8M48.3M3.4M5.1M
 
 
 
 
 
Net Cash Flow - Financing-678.3M-813.2M-2.5B-2.1B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash1.1M6.8M17.6M11.2M
 
 
 
 
 
 
Net Change In Cash-312.7M80.8M272.0M452.3M